Centers For Disease Control And Prevention

This early-stage study tests a new rotavirus vaccine delivered through a tiny-needle patch placed on the skin. Researchers want to see if it is safe and triggers an immune response in healthy adults aged 18 to 45. The vaccine is given in three doses, and participants are monitore…

This study tests whether two shorter, 17-week drug combinations can treat pulmonary tuberculosis as effectively as the standard 6-month regimen. About 288 adults and teens with active TB will take one of three daily pill regimens. The goal is to see if the shorter treatments clea…

This study was designed to test a program that would help caregivers of people with traumatic brain injury improve their problem-solving skills. It was withdrawn before any participants were enrolled, so no results are available.